Application
BRWD2 Antibody (Center) western blot analysis in mouse testis tissue lysates (15ug/lane).This demonstrates the BRWD2 antibody detected BRWD2 protein (arrow).Application
BRWD2 Antibody (Center) flow cytometric analysis of 293 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Product Name | BRWD2 Antibody (Center) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | WDR11; BRWD2; KIAA1351; WDR15; WD repeat-containing protein 11; Bromodomain and WD repeat-containing protein 2; WD repeat-containing protein 15 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBFC |
| WB:1:100~500 FC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | BRWD2 KIAA1351 WDR15 |
|---|---|
| Alternative Names | WDR11 BRWD2 KIAA1351 WDR15 WD repeat-containing protein 11 Bromodomain and WD repeat-containing protein 2 WD repeat-containing protein 15 |
| Molecular Weight(MW) | 136685 Da |
| Tissue Specificity | Ubiquitous. |
| Cellular Localization | Membrane; Single-pass membrane protein (Potential) |
| Entrez Gene | 55717 |
|---|---|
| Nucleotide Accession | NP_060587.8 |
Application
BRWD2 Antibody (Center) western blot analysis in mouse testis tissue lysates (15ug/lane).This demonstrates the BRWD2 antibody detected BRWD2 protein (arrow).
Application
BRWD2 Antibody (Center) flow cytometric analysis of 293 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Application Notes | WB:1:100~500 FC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
